About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

ZERIA PHARMACEUTICAL CO.,LTD.(4559) Summary

4559
TSE Prime
ZERIA PHARMACEUTICAL CO.,LTD.
2,431
JPY
+25
(+1.04%)
Dec 23, 3:30 pm JST
15.52
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
12.6
PBR
1.21
Yield
1.89%
Margin Trading Ratio
3.59
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
2,402 JPY 15.34 USD
Previous Close Dec 20
2,406 JPY 15.33 USD
High Dec 23, 3:00 pm
2,440 JPY 15.58 USD
Low Dec 23, 9:00 am
2,402 JPY 15.34 USD
Volume
34,300
Trading Value
0.08B JPY 0.53M USD
VWAP
2424.4 JPY 15.48 USD
Minimum Trading Value
243,100 JPY 1,552 USD
Market Cap
0.13T JPY 0.83B USD
Number of Trades
192
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
Mid
1-Year Average
266
1-Year High Feb 2, 2024
2,271
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 19,200 30,900 1.61
Dec 6, 2024 17,600 32,000 1.82
Nov 29, 2024 18,700 45,300 2.42
Nov 22, 2024 13,900 49,900 3.59
Nov 15, 2024 13,800 46,100 3.34
Company Profile
ZERIA PHARMACEUTICAL CO.,LTD. is a mid-tier pharmaceutical company focusing on gastrointestinal products. It also develops over-the-counter drugs such as the nutritional supplement "Hepalyse" and is expanding overseas.
Sector
Pharmaceuticals